PINATUZUMAB VEDOTIN
UNII 6KA1906BLC

Substance Identification & Data

This profile provides standardized clinical and technical data for Pinatuzumab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6KA1906BLC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1313706-14-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6KA1906BLC

CAS Registry Number

1313706-14-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PINATUZUMAB VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C104167

National Cancer Institute reference terminology for clinical and research data.

INN ID

9713

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-128

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pinatuzumab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PINATUZUMAB VEDOTIN

Common Names & Synonyms

ANTI-CD22-MONOMETHYL AURISTATIN E ANTIBODY-DRUG CONJUGATE

IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, BLYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E

PINATUZUMAB VEDOTIN [INN]

PINATUZUMAB VEDOTIN [USAN]

PINATUZUMAB VEDOTIN [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

SYS